Deutsche Bank Starts DocGo (DCGO) at Buy

Deutsche Bank analyst Pito Chickering initiates coverage on DocGo (NASDAQ: DCGO) with a Buy rating and a price target of $11.00.

The analyst commented, "DCGO has rapidly evolved its business model during COVID by creating an entirely new division called Mobile Health, which is the primary growth engine of medium-term earnings. We believe DCGO is still in the infancy of this new business model, which provides both plenty of upside as well as plenty of risk."

For an analyst ratings summary and ratings history on DocGo click here. For more ratings news on DocGo click here.

Shares of DocGo closed at $7.93 yesterday.

You May Also Be Interested In

• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
• Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings